Previous 10 | Next 10 |
“Do Tell” Your Doctor Tool was adapted from a clinically validated questionnaire developed by Duke University, with input from the Parkinson’s community Acorda Therapeutics, Inc. (NASDAQ: ACOR) today announced the launch of the “Do Tell” Your Doctor...
Acorda Therapeutics, Inc. (NASDAQ:ACOR) will host a conference call and webcast to report its third quarter 2019 update and financial results on Monday, November 4 at 4:30 p.m. ET. To participate in the conference call, please dial (833) 236-2756 (domestic) or (647) 689-4181 (internationa...
Acorda Therapeutics, Inc. (NASDAQ: ACOR) announced that Ron Cohen, M.D., Acorda’s President and Chief Executive Officer, will present at the 2019 Cantor Global Healthcare Conference on Friday, October 4 at 11:15AM ET. A live audio webcast of the presentation can be accessed under ...
Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it will present data at the International Congress of Parkinson’s Disease and Movement Disorders, taking place September 22-26, 2019 in Nice, France. The data include two posters, which will be presented on Tuesday, Sept...
Mitsubishi Tanabe Pharma America ( OTCPK:MTZPY -1.5% ) initiates a Phase 3 clinical trial, BouNDless , evaluating continuous subcutaneously administered carbidopa/levodopa (ND0612) compared to the oral formulation in Parkinson's disease (PD) patients. More news on: Mitsubishi Tanabe P...
Amarin (NASDAQ: AMRN ) initiated with Outperform rating and $26 (82% upside) price target at SVB Leerink. More news on: Amarin Corporation plc, Tenet Healthcare Corporation, Bristol-Myers Squibb Company, Healthcare stocks news, Stocks on the move, , Read more ...
Acorda Therapeutics ( ACOR ) recently reported a huge earnings beat in both earnings per share “EPS” and revenue. The company beat in Non-GAAP EPS of -$0.55 (beats by $0.51) and a GAAP EPS of -$0.58 (beats by $0.68), with revenue coming in at $50.05M which was a $21.22M bea...
Gainers: ABMD +5.7% . OBLN +5.6% . ACOR +5.1% . ERIC +4.2% . More news on: Abiomed, Inc., Obalon Therapeutics, Inc., Acorda Therapeutics, Inc., Stocks on the move, , News on ETFs Read more ...
The following slide deck was published by Acorda Therapeutics, Inc. in conjunction with their 2019 Q2 earnings Read more ...
Gainers: Aphria (NYSE: APHA ) +36% . Natural Grocers by Vitamin Cottage (NYSE: NGVC ) +33% . BlackLine (NASDAQ: BL ) +29% . Regional Health Properties (NYSEMKT: RHE ) +22% . Griffon Corporation (NYSE: GFF ) +20% . PC Connection (NASDAQ: CNXN ) +19% . Pinterest (NYSE: PINS ) +1...
News, Short Squeeze, Breakout and More Instantly...
Acorda Therapeutics Inc. Company Name:
ACOR Stock Symbol:
NASDAQ Market:
Acorda Therapeutics Inc. Website:
A look at the top 10 most actives in the United States Verb Technology Company Inc. (VERB) rose 11.3% to $0.2025 on volume of 40,515,259 shares Rallybio Corporation (RLYB) rose 80.4% to $2.9401 on volume of 39,492,767 shares Trio Petroleum Corp. (TPET) rose 36.3% to $0.2499 on volume of 3...
A look at the top 10 most actives in the United States Selina Hospitality PLC (SLNA) rose 28.8% to $0.0515 on volume of 62,068,605 shares Laser Photonics Corporation (LASE) rose 172.7% to $3.9 on volume of 54,588,758 shares WiSA Technologies Inc. (WISA) fell 6.1% to $0.0217 on volume of 2...
Acorda Therapeutics, Inc. (Nasdaq: ACOR) announced that Nasdaq Stock Market ("Nasdaq") today notified the Company that it will suspend trading in and delist the Company's common stock, effective with the opening of business on April 12, 2024. The notice follows the Company's April 1, 2024 announc...